Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
1 857.00
|
1 821.00
|
1 891.00
|
1 829.00
|
|
|
1 761 675 951.00
|
|
|
|
1 799.00
|
1 761.00
|
1 917.00
|
1 850.00
|
|
|
5 301 640 856.00
|
|
|
|
1 625.00
|
1 600.00
|
2 010.00
|
1 830.00
|
|
|
16 489 935 428.00
|
|
|
|
1 549.00
|
1 536.00
|
1 631.00
|
1 624.00
|
|
|
1 207 571 926.00
|
|
|
|
1 623.00
|
1 540.00
|
1 690.00
|
1 549.00
|
|
|
3 544 774 830.00
|
|
|
|
1 409.00
|
1 396.00
|
1 818.00
|
1 651.00
|
|
|
17 910 046 418.00
|
|
|
|
1 378.00
|
1 378.00
|
1 414.00
|
1 400.00
|
|
|
232 156 847.00
|
|
|
|
1 367.00
|
1 367.00
|
1 406.00
|
1 389.00
|
|
|
325 303 916.00
|
|
|
|
1 362.00
|
1 359.00
|
1 403.00
|
1 365.00
|
|
|
310 721 456.00
|
|
|
|
1 409.00
|
1 356.00
|
1 409.00
|
1 379.00
|
|
|
289 632 701.00
|
|
NeoImmuneTech, Inc. operates as a clinical-stage T cell-focused biotech company. The Company focuses on discovery and development of novel immuno-therapeutics. NeoImmuneTech serves customers in the United States.